Valuation: Progyny, Inc.

Capitalization 1.84B 1.56B 1.43B 1.35B 2.52B 174B 2.54B 16.99B 6.62B 83.56B 6.91B 6.77B 288B P/E ratio 2026 *
18.3x
P/E ratio 2027 * 16.7x
Enterprise value 1.67B 1.42B 1.3B 1.23B 2.29B 158B 2.31B 15.44B 6.02B 75.93B 6.28B 6.15B 262B EV / Sales 2026 *
1.21x
EV / Sales 2027 * 0.99x
Free-Float
81.19%
Yield 2026 *
-
Yield 2027 * -
1 day+23.80%
1 week+27.53%
Current month+27.66%
1 month+43.50%
3 months+9.56%
6 months+6.03%
Current year-7.63%
1 week 18.5
Extreme 18.5
23.76
1 month 16.16
Extreme 16.16
23.76
Current year 16.1
Extreme 16.1
28.75
1 year 16.1
Extreme 16.1
28.75
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2022
Director of Finance/CFO 60 15/09/2020
Chief Operating Officer 56 17/04/2025
Director TitleAgeSince
Chairman 66 01/01/2022
Director/Board Member 77 16/12/2016
Director/Board Member 58 01/01/2022
Change 5d. change 1-year change 3-years change Capi.($)
+23.80%+27.53%+11.94%-37.25% 1.84B
+2.77%+3.04%-0.17%-22.51% 345B
+1.38%+1.45%-6.55%-17.90% 82.1B
+1.42%+1.82%-13.61%+9.62% 76.2B
+11.27%+17.69%+10.19%-48.14% 33.01B
+1.78%+4.91%-10.88%-17.24% 27.63B
-3.08%-3.51%-42.29%-36.50% 9.69B
-1.75%-11.50%+18.58%+141.97% 3.71B
+10.64%+15.13%-11.11%+235.48% 1.64B
-0.23%+9.20%-14.79% - 298M
Average +4.80%+6.12%-5.87%+23.06% 58.12B
Weighted average by Cap. +2.79%+3.49%-3.34%-17.35%

Financials

2026 *2027 *
Net sales 1.38B 1.17B 1.07B 1.01B 1.89B 130B 1.9B 12.72B 4.96B 62.54B 5.17B 5.06B 216B 1.5B 1.27B 1.17B 1.1B 2.05B 142B 2.07B 13.83B 5.39B 68.04B 5.63B 5.51B 235B
Net income 109M 92.93M 85.05M 80.27M 150M 10.33B 151M 1.01B 393M 4.96B 410M 402M 17.13B 122M 104M 94.74M 89.42M 167M 11.51B 168M 1.12B 438M 5.53B 457M 447M 19.08B
Net Debt -168M -143M -131M -123M -230M -15.88B -232M -1.55B -604M -7.63B -631M -617M -26.33B -359M -305M -279M -263M -491M -33.9B -496M -3.31B -1.29B -16.29B -1.35B -1.32B -56.22B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
08/05/26 23.72 $ +23.80% 4,411,517
07/05/26 19.16 $ +2.46% 1,830,105
06/05/26 18.70 $ -1.48% 1,498,715
05/05/26 18.98 $ +0.37% 1,304,774
04/05/26 18.91 $ +1.67% 1,675,926
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
23.72USD
Average target price
27.91USD
Spread / Average Target
+17.66%

Quarterly revenue - Rate of surprise